Skip to main content

Tanguler Tolga's Form 4 filing

Alnylam Pharmaceuticals, Inc.ALNY · filed Oct 3, 2025

Accession no.
0001735276-25-000115
Filed
Oct 3, 2025
Trade date
Oct 1-2, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 13 non-derivative transactions. Open-market sales total $635.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tanguler TolgaCIK 0001849458Officer (EVP, Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2025Common StockAGrant or awardAcquired+2,851$0.00$028,843Direct
Oct 2, 2025Common StockSSaleDisposed−55$446.53F3−$24,559.1528,788Direct
Oct 2, 2025Common StockSSaleDisposed−27$447.92F4−$12,093.8428,761Direct
Oct 2, 2025Common StockSSaleDisposed−86$448.77F5−$38,594.2228,675Direct
Oct 2, 2025Common StockSSaleDisposed−119$449.79F6−$53,525.0128,556Direct
Oct 2, 2025Common StockSSaleDisposed−260$450.81F7−$117,210.628,296Direct
Oct 2, 2025Common StockSSaleDisposed−159$451.86F8−$71,845.7428,137Direct
Oct 2, 2025Common StockSSaleDisposed−319$452.69F9−$144,408.1127,818Direct
Oct 2, 2025Common StockSSaleDisposed−157$453.77F10−$71,241.8927,661Direct
Oct 2, 2025Common StockSSaleDisposed−117$454.84F11−$53,216.2827,544Direct
Oct 2, 2025Common StockSSaleDisposed−35$455.82F12−$15,953.727,509Direct
Oct 2, 2025Common StockSSaleDisposed−70$457.43−$32,020.127,439Direct
Oct 2, 2025Common StockSSaleDisposed−1$457.64−$457.6427,438Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $446.19 to $447.19. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F4

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $447.21 to $448.21. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $448.25 to $449.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $449.26 to $450.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $450.29 to $451.29. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $451.31 to $452.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F9

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $452.33 to $453.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F10

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $453.37 to $454.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F11

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $454.38 to $455.34. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F12

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $455.42 to $456.09. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)